Latest News

If you are wondering whether UiPath's current share price fairly reflects its prospects, you are in the right place for a clear look at what the numbers say about value. UiPath recently closed at US$10.09, with returns of a 4.9% decline over 7 days, an 8.9% decline over 30 days, a 36.5% decline year to date and a 10.9% decline over the last year, which many readers may see as a signal to reassess both risk and potential. Recent coverage has focused on UiPath's position in automation software...

As the Canadian market navigates a complex landscape marked by energy supply uncertainties and mixed economic signals, investors are keeping a close eye on growth companies that could potentially lead the way in a shifting environment. In this context, stocks with strong insider ownership often attract attention, as they can indicate confidence from those closest to the company's operations and strategic direction.

As global markets navigate a period of uncertainty, with energy supply disruptions and fluctuating economic indicators, investors are increasingly seeking opportunities in sectors that can offer resilience and potential growth. Penny stocks, despite their somewhat outdated moniker, represent an intriguing investment area for those interested in smaller or newer companies that might be poised for future success. By focusing on penny stocks with solid financial foundations, investors can...

Corteva (NYSE:CTVA) has outlined leadership teams for its planned separation into two public companies. The future seed and genetics entity, referred to as “SpinCo,” and the crop protection focused “New Corteva” will each have dedicated executive lineups. Former Albemarle CEO Luke Kissam has been named CEO of New Corteva as part of the announced leadership structure. The company continues to prepare for its targeted Q4 2026 split into two independent businesses. Corteva operates across...

Earlier this month, Privia Health reported quarterly revenue and earnings that exceeded analyst expectations and raised its full-year revenue guidance, highlighting stronger operating performance across its 13-state and Washington, D.C. footprint. Beneath the headline beat, the combination of improved profitability and an upgraded outlook contrasts with earlier concerns about subscale operations and negative returns on capital. We’ll now examine how this stronger-than-expected earnings...

The Canadian market, much like its global counterparts, is navigating a complex landscape where uncertainty around energy supply disruptions and geopolitical tensions looms large. Despite these challenges, the potential for small- and mid-cap stocks to sustain relative momentum offers intriguing opportunities for investors seeking growth. In this environment, identifying undiscovered gems requires a keen eye for companies with strong fundamentals that can thrive amidst cyclical shifts and...

As the Canadian market navigates a complex landscape of economic uncertainties and energy supply disruptions, investors are keenly observing how these factors might influence dividend stocks on the TSX. In such an environment, selecting dividend stocks that offer stability and reliable income can be particularly appealing, especially when they provide yields up to 5.6%.

Q1 2026 results set the tone for Roper Technologies (ROP) Roper Technologies (ROP) opened Q1 2026 earnings season with Q4 2025 revenue of US$2,058.6 million and basic EPS of US$4.00, backed by net income of US$428.4 million. Over the last few quarters, the company has seen revenue move from US$1,764.6 million in Q3 2024 to US$2,058.6 million in Q4 2025, while basic EPS shifted from US$3.43 to US$4.00. This gives investors a clearer view of how the top line and EPS are trending into the latest...

Immunome plans to present full Phase 3 RINGSIDE trial data for varegacestat in desmoid tumor patients at the 2026 ASCO Annual Meeting. The company expects to file a New Drug Application with the FDA for varegacestat after the ASCO presentation. The update highlights progress toward a potential new treatment option for this rare soft tissue tumor. For investors tracking Immunome, ticker NasdaqCM:IMNM, this update centers on a late stage program that could influence the company’s future...

If you are wondering whether Molson Coors Beverage is attractively priced at around US$42.87, the key is understanding what you are getting for that share price today. The stock has been under pressure over longer periods, with a 23.6% decline over the last year and a 9.6% drop year to date, although it has risen 4.2% over the past month while slipping 2.9% in the last week. Recent news flow around Molson Coors has focused on its position in the beverage sector and how investors are weighing...

Earlier this month, Travere Therapeutics announced that the FDA approved FILSPARI (sparsentan) to reduce proteinuria in adults and children aged 8 and older with focal segmental glomerulosclerosis (FSGS) without nephrotic syndrome, making it the first and only approved therapy for this rare kidney disease. This approval, backed by the large Phase 3 DUPLEX Study and aligned with KDIGO guidelines, extends FILSPARI’s reach beyond IgA nephropathy into a second rare kidney indication and expands...

If you are wondering whether Toyota Tsusho at ¥6,100 still offers value, the key is understanding how its current price lines up with different valuation checks. The stock is up 10.8% year to date, with a 142.7% return over the past year, even though the last 7 and 30 days show modest declines of 2.3% and 2.1%. Recent coverage has focused on Toyota Tsusho as part of broader discussions around major Japanese trading houses and their roles in global supply chains, resource sourcing, and...

Betterware de México, S.A.P.I. de C.V. reported past first-quarter 2026 results with sales of MX$3,509.7 million, slightly above the prior year’s MX$3,499.15 million, and net income of MX$281.34 million versus MX$151.39 million. The sharp improvement in profit despite broadly flat revenue suggests the company has recently become more efficient in converting sales into earnings. Next, we’ll examine how this stronger profitability trend could influence Betterware de México’s investment...

C3.ai (AI) is back in focus after recent coverage highlighted its share price gaining about 9% over the past month, outpacing its industry while analysts discuss a possible shift toward positive earnings in the next fiscal year. See our latest analysis for C3.ai. Despite the recent 9% gain over the past month, the share price tells a tougher story. The 90-day share price return shows a decline of about 33%, and the 1-year total shareholder return shows a decline of about 61%. This suggests...

Tapestry stock update: what recent returns say about investor sentiment Tapestry (TPR) has drawn investor attention after a strong past 3 months, with a 12.6% total return and a last close of $146.45, set against mixed shorter term share performance. See our latest analysis for Tapestry. While the share price has eased 2.8% over the past week, Tapestry’s 90 day share price return of 12.6% and very large 5 year total shareholder return suggest momentum has been firmly positive over a longer...

Cosmo (SWX:COPN) is back in focus after reporting 12 month Phase III results for its Clascoterone 5% topical solution in male androgenetic alopecia, highlighting long term safety, ongoing efficacy and preparation for global regulatory filings. See our latest analysis for Cosmo. The latest clinical update comes after a mixed period in the market, with a 23.6% 1 month share price return and a 16.99% 3 month decline. Meanwhile, the 1 year total shareholder return sits at 111.93%, suggesting...

Simply Business, a subsidiary of Travelers Companies, has launched an AI powered insurance app for small businesses in the US. The new app, available on ChatGPT, is designed to streamline the quoting process for small business insurance. The launch introduces a new use of artificial intelligence within Travelers Companies' global operations. Travelers Companies (NYSE:TRV) is adding a fresh technology angle to its profile with this new AI app from Simply Business. The move comes as the...

Iridium Communications (IRDM) Q1 2026 earnings snapshot Iridium Communications (IRDM) has entered Q1 2026 with trailing 12 month revenue of US$871.7 million and basic EPS of US$1.07, backed by net income of US$114.4 million. The most recent reported quarter, Q4 2025, delivered revenue of US$212.9 million and basic EPS of US$0.24. Over the past six reported quarters, revenue has ranged between US$212.8 million and US$226.9 million, with quarterly basic EPS moving between US$0.21 and US$0.35...

Event overview and recent share performance Madison Air Solutions (MAIR) shares recently showed mixed short term moves, with a 1.2% decline over the past day and a 7.8% gain over the past week. This has drawn attention to how investors are pricing its air quality business. See our latest analysis for Madison Air Solutions. With a 7.8% year to date share price return at a current share price of $34.24, recent gains suggest improving short term momentum after a softer 1 day move, while the...

If you are wondering whether Kimbell Royalty Partners at around US$14.59 still offers value, the key question is how its current price lines up with its fundamentals and cash flows. The units have returned 1.0% over the last 7 days, around flat at 0.5% over 30 days, and are up 21.3% year to date and 33.0% over the past year, which may have shifted how some investors view its risk and reward profile. Recent attention on Kimbell Royalty Partners has focused on its role in the US energy sector...

Wondering if WSP Global at around C$225 per share is offering fair value right now, or if the price is out of sync with the underlying business. The stock has seen a 0.5% decline over the last week and a 3.7% gain over the last 30 days, while year to date it is down 9.8% and the 1 year return sits at a 10.5% decline, compared with gains of 27.7% over 3 years and 82.6% over 5 years. These mixed returns arrive against a backdrop of ongoing interest in engineering and professional services...

DuPont de Nemours (NYSE:DD) has set new 2035 Sustainability Goals centered on sustainable innovation, resilient operations, and community engagement. The company recently introduced an AI-enabled RO Operations Advisor tool aimed at optimizing industrial water treatment processes. DuPont also launched ultrapure fluid transfer assemblies aimed at biopharma manufacturing and healthcare production environments. For investors watching materials and specialty chemicals, these moves illustrate how...

If you are wondering whether Main Street Capital's current share price lines up with its underlying value, a key consideration is how the market is weighing its income profile against the risks in the wider capital markets sector. The stock recently closed at US$54.02, with returns of 1.0% over 7 days, a 1.5% decline over 30 days, a 12.5% decline year to date, and gains of 6.2% over 1 year, 71.3% over 3 years, and 84.8% over 5 years. These figures may shape how you think about both...

The United States market has remained flat over the past week but has seen an impressive 30% rise over the past year, with earnings projected to grow by 16% annually. In this context, identifying stocks that are perceived as undervalued can be particularly appealing, especially when there is insider buying which may suggest confidence in their potential.